These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8854394)
1. Pharmacokinetics of oral ranitidine in Mexicans. Castañeda-Hernández G; Flores-Murrieta FJ; Granados-Soto V; Herrera-Abarca A; Pérez-Urizar J; Herrera JE; Hong E Arch Med Res; 1996; 27(3):349-52. PubMed ID: 8854394 [TBL] [Abstract][Full Text] [Related]
2. Determination of oral rifampin pharmacokinetic parameters in Mexicans and comparison with other populations: absence of evidence for interethnic variability. Flores-Murrieta FJ; Castañeda-Hernández G; Herrera JE; Hong E Arch Med Res; 1994; 25(4):381-5. PubMed ID: 7858395 [TBL] [Abstract][Full Text] [Related]
3. Effects of gender and phase of the menstrual cycle on the kinetics of ranitidine in healthy volunteers. Flores Pérez J; Juárez Olguín H; Flores Pérez C; Pérez Guillé G; Guillé Pérez A; Camacho Vieyra A; Toledo López A; Carrasco Portugal M; Lares Asseff I Chronobiol Int; 2003 May; 20(3):485-94. PubMed ID: 12868543 [TBL] [Abstract][Full Text] [Related]
4. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [TBL] [Abstract][Full Text] [Related]
5. Bioavailability of ranitidine in healthy Mexican volunteers: effect of food. Juárez-Olguín H; Flores J; Pérez G; Hernández G; Flores C; Guillé A; Camacho A; Toledo A; Carrasco M; Lares I Proc West Pharmacol Soc; 2002; 45():156-8. PubMed ID: 12434565 [TBL] [Abstract][Full Text] [Related]
6. [Bioequivalence and bioavailability after single administration of effervescent ranitidine tablets]. Hartmann B; Schmieder G; Tetzloff W; Töberich H Arzneimittelforschung; 1992 Aug; 42(8):1020-2. PubMed ID: 1418073 [TBL] [Abstract][Full Text] [Related]
7. Comparative bioavailability of two oral formulations of ranitidine. Flores-Murrieta FJ; Toledo A; del Carmen Carrasco-Portugal M; Reyes-García G; Rodríguez-Silverio J; Medina-Santillán R; Herrera JE Biopharm Drug Dispos; 2006 Jan; 27(1):23-7. PubMed ID: 16278926 [TBL] [Abstract][Full Text] [Related]
8. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers. Bawazir SA; Gouda MW; El-Sayed YM; Al-Khamis KI; Al-Yamani MJ; Niazy EM; Al-Rashood KA Int J Clin Pharmacol Ther; 1998 May; 36(5):270-4. PubMed ID: 9629991 [TBL] [Abstract][Full Text] [Related]
9. Effect of age on the pharmacokinetics of ranitidine in healthy Mexican volunteers. Pérez-Guillé G; Guillé-Pérez A; Toledo-López A; Juárez-Olguín H; Flores Pérez C; Flores-Pŕez J; Carrasco-Portugal M; Lares-Asseff I; Camacho-Vieyra A Proc West Pharmacol Soc; 2005; 48():84-8. PubMed ID: 16416668 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of ranitidine and famotidine in healthy elderly subjects: a double-blind, placebo-controlled comparison. Bisson C; St-Laurent M; Michaud JT; LeBel M Pharmacotherapy; 1993; 13(1):3-9. PubMed ID: 8437966 [TBL] [Abstract][Full Text] [Related]
11. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic profile of talipexole in healthy volunteers is not altered when it is co-administered with Madopar (co-beneldopa). Zhang TT; Song M; Hang TJ; Xu XF; Wen AD; Yang L; Jia L J Clin Pharm Ther; 2009 Jun; 34(3):345-54. PubMed ID: 19646081 [TBL] [Abstract][Full Text] [Related]
13. Effect of Da-Cheng-Qi decoction on the pharmacokinetics of ranitidine in rats. Tang WF; Wan MH; Huang QR; Zhu ZY; Zhao JL; Wu YZ; Huang X Biomed Chromatogr; 2008 Aug; 22(8):851-6. PubMed ID: 18384065 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction study between ranitidine and metoclopramide. Leucuţa A; Vlase L; Farcău D; Nanulescu M Rom J Gastroenterol; 2004 Sep; 13(3):211-4. PubMed ID: 15470533 [TBL] [Abstract][Full Text] [Related]
15. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers. Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the oral pharmacokinetics of fluconazole and itraconazole in Mexicans. Flores-Murrieta FJ; Carrasco-Portugal Mdel C; Landa C Proc West Pharmacol Soc; 2008; 51():63-5. PubMed ID: 19544680 [TBL] [Abstract][Full Text] [Related]
17. Study on the bioequivalence of two ranitidine formulations. Hilgenstock C; Schmiedel G; Bührens KG Arzneimittelforschung; 1987 Aug; 37(8):974-6. PubMed ID: 3675698 [TBL] [Abstract][Full Text] [Related]
18. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers. Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584 [TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers. Bareggi SR; Gambaro V; Valenti M; Benvenuti C Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373 [TBL] [Abstract][Full Text] [Related]
20. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus. von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]